血漿治療の世界市場（2022年～2026年）

世界の血漿治療の市場規模は、2022年～2026年の間に89億8,000万米ドルの増加が見込まれ、予測期間中に6.1％のCAGRで成長すると予測されています。

市場を牽引する要因には、中国におけるアルブミンの高い需要、外科手術の増加、政府機関による新たな承認などが挙げられます。

当レポートでは、世界の血漿治療市場について調査分析し、市場規模、予測、動向、成長促進要因、課題、約25社のベンダーを網羅したベンダー分析など、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場のエコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模：2021年
• 市場の見通し：2021年～2026年の予測

第4章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競合企業の脅威
• 市況

第5章 製品別の市場セグメンテーション

• 市場セグメント
• 製品別の比較
• 免疫グロブリン：市場規模と予測（2021年～2026年）
• アルブミン：市場規模と予測（2021年～2026年）
• 血液因子：市場規模と予測（2021年～2026年）
• その他：市場規模と予測（2021年～2026年）
• 製品別の市場機会

第6章 顧客情勢

• 顧客情勢の概要

第7章 地域別情勢

• 地域別セグメンテーション
• 地域別の比較
• 北米：市場規模と予測（2021年～2026年）
• 欧州：市場規模と予測（2021年～2026年）
• アジア：市場規模と予測（2021年～2026年）
• その他の地域（ROW）：市場規模と予測（2021年～2026年）
• 米国：市場規模と予測（2021年～2026年）
• ドイツ：市場規模と予測（2021年～2026年）
• 英国：市場規模と予測（2021年～2026年）
• カナダ：市場規模と予測（2021年～2026年）
• 中国：市場規模と予測（2021年～2026年）
• 地域情勢別の市場機会

第8章 促進要因・課題・動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第9章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱情勢
• 業界のリスク

第10章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• ADMA Biologics Inc.
• Bio Products Laboratory Ltd.
• CSL Ltd.
• Grifols SA
• Kamada Ltd.
• Kedrion Spa
• Octapharma AG
• Prothya Biosolutions Netherlands BV
• SK Discovery Co. Ltd.
• Takeda Pharmaceutical Co. Ltd.

第11章 付録

Technavio has been monitoring the plasma therapeutics market and it is poised to grow by $ 8.98 bn during 2022-2026 progressing at a CAGR of 6.1% during the forecast period. Our report on the plasma therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the high demand for albumin in China, increasing surgical procedures, and new approvals by governing bodies.

The plasma therapeutics market analysis includes the product segment and geographic landscape.

Technavio's plasma therapeutics market is segmented as below:

By Product

• Immunoglobulin
• Albumin
• Blood factors
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the establishment of plasma fractionation facilities in developing economies by global players as one of the prime reasons driving the plasma therapeutics market growth during the next few years. Also, strategic initiatives of vendors fueling the market growth and increasing awareness of the importance of early diagnosis will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on plasma therapeutics market covers the following areas:

• Plasma therapeutics market sizing
• Plasma therapeutics market forecast
• Plasma therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading plasma therapeutics market vendors that include ADMA Biologics Inc., Bio Products Laboratory Ltd., BIOPHARMA PLASMA, CSL Ltd., Emergent BioSolutions Inc., Evolve Biologics Inc., Grifols SA, Kamada Ltd., Kedrion Spa, Octapharma AG, Pfizer Inc., Prothya Biosolutions Netherlands BV, SK Discovery Co. Ltd., and Takeda Pharmaceutical Co. Ltd. Also, the plasma therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary - Chart on Incremental Growth
• Exhibit 07: Executive Summary - Data Table on Incremental Growth
• Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 12: Market segments
• 3.3 Market size 2021
• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between2021 and 2026
• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

• 5.1 Market segments
• Exhibit 24: Chart on Product - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
• 5.2 Comparison by Product
• Exhibit 26: Chart on Comparison by Product
• Exhibit 27: Data Table on Comparison by Product
• 5.3 Immunoglobulin - Market size and forecast 2021-2026
• Exhibit 28: Chart on Immunoglobulin - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Immunoglobulin - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Immunoglobulin - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Immunoglobulin - Year-over-year growth 2021-2026 (%)
• 5.4 Albumin - Market size and forecast 2021-2026
• Exhibit 32: Chart on Albumin - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Albumin - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Albumin - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Albumin - Year-over-year growth 2021-2026 (%)
• 5.5 Blood factors - Market size and forecast 2021-2026
• Exhibit 36: Chart on Blood factors - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Blood factors - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Blood factors - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Blood factors - Year-over-year growth 2021-2026 (%)
• 5.6 Others - Market size and forecast 2021-2026
• Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
• Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
• 5.7 Market opportunity by Product
• Exhibit 44: Market opportunity by Product ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• 7.2 Geographic comparison
• Exhibit 48: Chart on Geographic comparison
• Exhibit 49: Data Table on Geographic comparison
• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• 7.7 US - Market size and forecast 2021-2026
• Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
• 7.8 Germany - Market size and forecast 2021-2026
• Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• 7.9 UK - Market size and forecast 2021-2026
• Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
• 7.10 Canada - Market size and forecast 2021-2026
• Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• 7.11 China - Market size and forecast 2021-2026
• Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
• 7.12 Market opportunity By Geographical Landscape
• Exhibit 86: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers
• 8.2 Market challenges
• 8.3 Impact of drivers and challenges
• Exhibit 87: Impact of drivers and challenges in 2021 and 2026
• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview
• 9.2 Vendor landscape
• Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
• 9.3 Landscape disruption
• Exhibit 89: Overview on factors of disruption
• 9.4 Industry risks
• Exhibit 90: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 91: Vendors covered
• 10.2 Market positioning of vendors
• Exhibit 92: Matrix on vendor position and classification
• 10.3 ADMA Biologics Inc.
• Exhibit 93: ADMA Biologics Inc. - Overview
• Exhibit 94: ADMA Biologics Inc. - Business segments
• Exhibit 95: ADMA Biologics Inc. - Key offerings
• Exhibit 96: ADMA Biologics Inc. - Segment focus
• 10.4 Bio Products Laboratory Ltd.
• Exhibit 97: Bio Products Laboratory Ltd. - Overview
• Exhibit 98: Bio Products Laboratory Ltd. - Product / Service
• Exhibit 99: Bio Products Laboratory Ltd. - Key offerings
• 10.5 CSL Ltd.
• Exhibit 100: CSL Ltd. - Overview
• Exhibit 101: CSL Ltd. - Business segments
• Exhibit 102: CSL Ltd. - Key news
• Exhibit 103: CSL Ltd. - Key offerings
• Exhibit 104: CSL Ltd. - Segment focus
• 10.6 Grifols SA
• Exhibit 105: Grifols SA - Overview
• Exhibit 106: Grifols SA - Business segments
• Exhibit 107: Grifols SA - Key offerings
• Exhibit 108: Grifols SA - Segment focus
• 10.7 Kamada Ltd.
• Exhibit 109: Kamada Ltd. - Overview
• Exhibit 110: Kamada Ltd. - Product / Service
• Exhibit 111: Kamada Ltd. - Key offerings
• 10.8 Kedrion Spa
• Exhibit 112: Kedrion Spa - Overview
• Exhibit 113: Kedrion Spa - Product / Service
• Exhibit 114: Kedrion Spa - Key offerings
• 10.9 Octapharma AG
• Exhibit 115: Octapharma AG - Overview
• Exhibit 116: Octapharma AG - Product / Service
• Exhibit 117: Octapharma AG - Key offerings
• 10.10 Prothya Biosolutions Netherlands BV
• Exhibit 118: Prothya Biosolutions Netherlands BV - Overview
• Exhibit 119: Prothya Biosolutions Netherlands BV - Product / Service
• Exhibit 120: Prothya Biosolutions Netherlands BV - Key offerings
• 10.11 SK Discovery Co. Ltd.
• Exhibit 121: SK Discovery Co. Ltd. - Overview
• Exhibit 122: SK Discovery Co. Ltd. - Product / Service
• Exhibit 123: SK Discovery Co. Ltd. - Key offerings
• 10.12 Takeda Pharmaceutical Co. Ltd.
• Exhibit 124: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibit 125: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 126: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibit 127: Takeda Pharmaceutical Co. Ltd. - Key offerings

11 Appendix

• 11.1 Scope of the report
• 11.2 Inclusions and exclusions checklist
• Exhibit 128: Inclusions checklist
• Exhibit 129: Exclusions checklist
• 11.3 Currency conversion rates for US$
• Exhibit 130: Currency conversion rates for US$
• 11.4 Research methodology
• Exhibit 131: Research methodology
• Exhibit 132: Validation techniques employed for market sizing
• Exhibit 133: Information sources
• 11.5 List of abbreviations
• Exhibit 134: List of abbreviations

Exhibits

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Product
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Vendor Market Positioning
• Exhibits9: Parent market
• Exhibits10: Market Characteristics
• Exhibits11: Offerings of vendors included in the market definition
• Exhibits12: Market segments
• Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits17: Five forces analysis - Comparison between2021 and 2026
• Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
• Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
• Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
• Exhibits23: Chart on Market condition - Five forces 2021 and 2026
• Exhibits24: Chart on Product - Market share 2021-2026 (%)
• Exhibits25: Data Table on Product - Market share 2021-2026 (%)
• Exhibits26: Chart on Comparison by Product
• Exhibits27: Data Table on Comparison by Product
• Exhibits28: Chart on Immunoglobulin - Market size and forecast 2021-2026 ($ million)
• Exhibits29: Data Table on Immunoglobulin - Market size and forecast 2021-2026 ($ million)
• Exhibits30: Chart on Immunoglobulin - Year-over-year growth 2021-2026 (%)
• Exhibits31: Data Table on Immunoglobulin - Year-over-year growth 2021-2026 (%)
• Exhibits32: Chart on Albumin - Market size and forecast 2021-2026 ($ million)
• Exhibits33: Data Table on Albumin - Market size and forecast 2021-2026 ($ million)
• Exhibits34: Chart on Albumin - Year-over-year growth 2021-2026 (%)
• Exhibits35: Data Table on Albumin - Year-over-year growth 2021-2026 (%)
• Exhibits36: Chart on Blood factors - Market size and forecast 2021-2026 ($ million)
• Exhibits37: Data Table on Blood factors - Market size and forecast 2021-2026 ($ million)
• Exhibits38: Chart on Blood factors - Year-over-year growth 2021-2026 (%)
• Exhibits39: Data Table on Blood factors - Year-over-year growth 2021-2026 (%)
• Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
• Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
• Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
• Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
• Exhibits44: Market opportunity by Product ($ million)
• Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits48: Chart on Geographic comparison
• Exhibits49: Data Table on Geographic comparison
• Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
• Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
• Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
• Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits82: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibits83: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibits84: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibits85: Data Table on China - Year-over-year growth 2021-2026 (%)
• Exhibits86: Market opportunity By Geographical Landscape ($ million)
• Exhibits87: Impact of drivers and challenges in 2021 and 2026
• Exhibits88: Overview on Criticality of inputs and Factors of differentiation
• Exhibits89: Overview on factors of disruption
• Exhibits90: Impact of key risks on business
• Exhibits91: Vendors covered
• Exhibits92: Matrix on vendor position and classification
• Exhibits93: ADMA Biologics Inc. - Overview
• Exhibits94: ADMA Biologics Inc. - Business segments
• Exhibits95: ADMA Biologics Inc. - Key offerings
• Exhibits96: ADMA Biologics Inc. - Segment focus
• Exhibits97: Bio Products Laboratory Ltd. - Overview
• Exhibits98: Bio Products Laboratory Ltd. - Product / Service
• Exhibits99: Bio Products Laboratory Ltd. - Key offerings
• Exhibits100: CSL Ltd. - Overview
• Exhibits101: CSL Ltd. - Business segments
• Exhibits102: CSL Ltd. - Key news
• Exhibits103: CSL Ltd. - Key offerings
• Exhibits104: CSL Ltd. - Segment focus
• Exhibits105: Grifols SA - Overview
• Exhibits106: Grifols SA - Business segments
• Exhibits107: Grifols SA - Key offerings
• Exhibits108: Grifols SA - Segment focus
• Exhibits109: Kamada Ltd. - Overview
• Exhibits110: Kamada Ltd. - Product / Service
• Exhibits111: Kamada Ltd. - Key offerings
• Exhibits112: Kedrion Spa - Overview
• Exhibits113: Kedrion Spa - Product / Service
• Exhibits114: Kedrion Spa - Key offerings
• Exhibits115: Octapharma AG - Overview
• Exhibits116: Octapharma AG - Product / Service
• Exhibits117: Octapharma AG - Key offerings
• Exhibits118: Prothya Biosolutions Netherlands BV - Overview
• Exhibits119: Prothya Biosolutions Netherlands BV - Product / Service
• Exhibits120: Prothya Biosolutions Netherlands BV - Key offerings
• Exhibits121: SK Discovery Co. Ltd. - Overview
• Exhibits122: SK Discovery Co. Ltd. - Product / Service
• Exhibits123: SK Discovery Co. Ltd. - Key offerings
• Exhibits124: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibits125: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibits126: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibits127: Takeda Pharmaceutical Co. Ltd. - Key offerings
• Exhibits128: Inclusions checklist
• Exhibits129: Exclusions checklist
• Exhibits130: Currency conversion rates for US$
• Exhibits131: Research methodology
• Exhibits132: Validation techniques employed for market sizing
• Exhibits133: Information sources
• Exhibits134: List of abbreviations